However, two studies evaluated peak GH level variability using insulin, and both concluded that the time after insulin injection determines the severity of hypoglycemia, with durations less than 90 minutes indicating safety and cost-effectiveness [14,15]. The gene discussed is INS; the disease is Hypoglycemia.